Tradestie Institutional Equity Comparison Engine

OKYO vs NBIX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

NBIX Overall Edge

NBIX Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Neurocrine Biosciences Inc (NBIX) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, OKYO trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus NBIX at 12.2x Forward P/E and 26.6% operating margin (+41.2% YoY). In options structure, OKYO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against NBIX sits in CONSOLIDATION (26th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner NBIX
OKYO N/M vs NBIX 12.2x Fwd P/E
Growth & Margin Winner NBIX
Op Margin 0.0% vs 26.6% ยท YoY +0.0% vs +41.2%
Momentum & Technical Winner NBIX
1Y -47.0% vs +9.1% ยท 52W Pos 3% vs 44%
Options & Structure Winner NBIX
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (26th %ile IV)
OKYO NASDAQ
OKYO Pharma Limited Ordinary Shares
Biological Products, (No Diagnostic Substances)
$1.07
-7.76% 1D
Market Cap $62.7M
1M Return -27.21%
1Y Return -47.03%
Forward P/E N/M
Unified AI Score
42.8 / 100 HOLD
Tech 38.0 Fund 54.0 Flow 50.0 Mom 45.0
NBIX NASDAQ
Neurocrine Biosciences Inc
Biological Products, (No Disgnostic Substances)
$150.57
-3.84% 1D
Market Cap $15.8B
1M Return +5.08%
1Y Return +9.06%
Forward P/E 12.2x
Unified AI Score
40.0 / 100 SELL
Tech 20.0 Fund 46.0 Flow 67.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: OKYO -47.03% NBIX +9.06% Spread: +56.09 pp (NBIX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
OKYO TTM Op. Margin: 0.0% NBIX TTM Op. Margin: 26.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on OKYO vs NBIX. Trailing 12-month operating profitability (OKYO 0.0% vs NBIX 26.6%) and valuation multiples (OKYO N/M vs NBIX 12.2x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: OKYO (1) vs NBIX (9)
Institutional Metric OKYO NBIX Criterion Row Winner
Market Capitalization Scale $62.7M $15.8B Larger Scale NBIX
Trailing P/E Ratio Valuation N/M 24.2x Lower Multiple NBIX
Forward P/E Ratio Valuation N/M 12.2x Lower Multiple NBIX
Revenue Growth (YoY) Growth +0.0% +41.2% Higher Growth NBIX
Operating Margin (TTM) Profitability 0.0% 26.6% Higher Margin NBIX
Net Profit Margin Profitability 0.0% 19.0% Higher Margin NBIX
Return on Equity (ROE) Capital Efficiency -263.8% 20.4% Higher ROE NBIX
52-Week Range Position Momentum 3% ($1โ€“$3) 44% ($122โ€“$186) Stronger Trend NBIX
Beta / 30D Volatility Risk Regime 1.00ฮฒ ยท 76% Vol 0.67ฮฒ ยท 56% Vol Lower Realized Risk NBIX
Unified Institutional Score Composite Signal 42.8 / 100 (HOLD) 40.0 / 100 (SELL) Higher Composite OKYO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full OKYO vs NBIX Buy Guide
OKYO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live OKYO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
NBIX CONSOLIDATION
95d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 26th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live NBIX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither OKYO nor NBIX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.